Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Dmochowski

Showing results (91-100 of 184) with videos related to

Pageof 19
Sort By:
The Journal of Urology|April 12, 2005
The overactive bladder-symptom composite score: a composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladderNorman Zinner, Mark Harnett, Luann Sabounjian, et al.
Urology|June 30, 2020
AUTHOR REPLYShokhi Goel, Hudson Pierce, Kevin Pain, et al.
Urology|March 22, 2020
Use of Botulinum Toxin A (BoNT-A) in Detrusor External Sphincter Dyssynergia (DESD): A Systematic Review and Meta-analysisShokhi Goel, Hudson Pierce, Kevin Pain, et al.
World Journal of Urology|August 22, 2019
Can men with lower urinary tract symptoms (LUTs) predict voided volumes?Mitali Kini, Dominique Thomas, Nadir Zaidi, et al.
The Journal of Urology|December 14, 2012
Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trialRoger Dmochowski, Claus Roehrborn, Suzanne Klise, et al.
The Journal of Urology|February 28, 2019
Patient Characteristics that May Influence the Effect of Urethral Injection Therapy for Female Stress Urinary IncontinenceMarlene Elmelund, Eric R Sokol, Mickey M Karram, et al.
Journal of Clinical Pharmacology|July 20, 2005
Effect of the proton pump inhibitor omeprazole on the pharmacokinetics of extended-release formulations of oxybutynin and tolterodineRoger Dmochowski, Andrew Chen, Gayatri Sathyan, et al.
The Journal of Urology|January 23, 2010
Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trialRoger Dmochowski, Claus Roehrborn, Suzanne Klise, et al.
American Journal of Obstetrics and Gynecology|July 25, 2016
Incontinence rates after midurethral sling revision for vaginal exposure or painLisa H Jambusaria, Jessica Heft, W Stuart Reynolds, et al.
Neurourology and Urodynamics|April 27, 2017
Under what circumstances should stress incontinence surgery be performed at the same time as prolapse surgery? ICI-RS 2015Vik Khullar, Ralf Anding, Dudley Robinson, et al.
Pageof 19

Showing results (91-100 of 184) with videos related to

Sort By:
Pageof 19
The Journal of Urology|April 12, 2005
The overactive bladder-symptom composite score: a composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladderNorman Zinner, Mark Harnett, Luann Sabounjian, et al.
Urology|June 30, 2020
AUTHOR REPLYShokhi Goel, Hudson Pierce, Kevin Pain, et al.
Urology|March 22, 2020
Use of Botulinum Toxin A (BoNT-A) in Detrusor External Sphincter Dyssynergia (DESD): A Systematic Review and Meta-analysisShokhi Goel, Hudson Pierce, Kevin Pain, et al.
World Journal of Urology|August 22, 2019
Can men with lower urinary tract symptoms (LUTs) predict voided volumes?Mitali Kini, Dominique Thomas, Nadir Zaidi, et al.
The Journal of Urology|December 14, 2012
Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trialRoger Dmochowski, Claus Roehrborn, Suzanne Klise, et al.
The Journal of Urology|February 28, 2019
Patient Characteristics that May Influence the Effect of Urethral Injection Therapy for Female Stress Urinary IncontinenceMarlene Elmelund, Eric R Sokol, Mickey M Karram, et al.
Journal of Clinical Pharmacology|July 20, 2005
Effect of the proton pump inhibitor omeprazole on the pharmacokinetics of extended-release formulations of oxybutynin and tolterodineRoger Dmochowski, Andrew Chen, Gayatri Sathyan, et al.
The Journal of Urology|January 23, 2010
Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trialRoger Dmochowski, Claus Roehrborn, Suzanne Klise, et al.
American Journal of Obstetrics and Gynecology|July 25, 2016
Incontinence rates after midurethral sling revision for vaginal exposure or painLisa H Jambusaria, Jessica Heft, W Stuart Reynolds, et al.
Neurourology and Urodynamics|April 27, 2017
Under what circumstances should stress incontinence surgery be performed at the same time as prolapse surgery? ICI-RS 2015Vik Khullar, Ralf Anding, Dudley Robinson, et al.
Pageof 19